Pancreatic cancer remains one of the most challenging cancers to treat due to its aggressive nature and typically late-stage diagnosis. With a low survival rate and limited treatment options, there is a growing need for advanced therapies, including targeted treatments and immunotherapies. This article offers an in-depth analysis of the advanced pancreatic cancer drug pipeline, exploring the...